Technology & Devices

Vaccinex Enters Deal with Five Prime Therapeutics Utilizing Vaccinex’s Antibody Discovery Platform

Privately-held clinical-stage immunotherapy company, Vaccinex, Inc., recently announced that it has signed a multi-target antibody discovery deal with Five Prime Therapeutics. Vaccinex said that it has entered into a multi-target collaboration agreement with Five Prime to utilize Vaccinex’s ActivMab antibody discovery platform for the discovery of monoclonal antibodies against novel …

Read More »

Myriad Expands Collaboration with BioMarin for Cancer Companion Diagnostic Test

Myriad Genetics recently announced that it has expanded its collaboration with BioMarin Pharmaceutical to use Myriad’s myChoice HRD companion diagnostic test. Under the deal, BioMarin will use Myriad’s myChoice HRD companion diagnostic test to prospectively identify patients with metastatic breast, ovarian and potentially other tumor types that may be sensitive …

Read More »

Respiratory Biotech Pulmatrix to Merge with Ruthigen

Respiratory biotech Pulmatrix announced an agreement to merge with publicly traded, biopharmaceutical company Ruthigen. The companies have entered into a definitive merger agreement, under which Pulmatrix will become a wholly-owned subsidiary of Ruthigen – which would take the Pulmatrix name and continue Pulmatrix’s work of advancing a new generation of …

Read More »

Biosimilars 20/20: A Market Analysis of the Growth and Implications of Biosimilars Over the Next Five Years

TAMPA, FL, March 16, 2015 — The biosimilars event of the year – Biosimilars 20/20 – is scheduled for June 3-4, 2015 at The Hub in Philadelphia, PA. The event promises to provide an in-depth look into the future of the biosimilars market and address challenges of implementation. Biosimilars 20/20 …

Read More »

FDNA to Launch Online Forum for the Genetics Expert Community

Pioneer in computer-aided dysmorphology analysis, FDNA, announced that it will launch an online forum for the genetics expert community for undiagnosed and challenging cases. The company said that it will unveil the “Unknown Forum” at the Annual Clinical Genetics Meeting ACMG 2015 in Salt Lake City, UT on March 26, …

Read More »

CMS Expands Telemedicine Services Coverage through New ACO Model

The Centers for Medicare & Medicaid Services (CMS) is launching a Next Generation Accountable Care Organization (ACO) Model of payment and care delivery, an initiative that will extend coverage for telemedicine services to millions of Medicare beneficiaries. Telemedicine is defined as clinicians encountering patients remotely in real time through audio …

Read More »

Genetic Test Maker 23andMe Hires Biotech Executive to Lead its Drug Development Effort

Google-backed genetic-testing company 23andMe is launching its own drug development unit, and bringing on former Genentech executive to become its chief scientist and lead the company’s research and development efforts. 23andMe has collected genetic information from more than 850,000 customers worldwide from its $99 DNA spit test and more than …

Read More »

Biodesix to Collaborate with Inivata for NGS-Based Lung Cancer Tests

Molecular diagnostics company Biodesix, Inc. is teaming up with clinical cancer genomics company Inivata to develop Next Generation Sequencing (NGS)-blood based tests for lung cancer. The companies announced their partnership to develop and commercialize these tests for clinical applications in lung cancer, leveraging Inivata’s proprietary, enhanced Tam-Seq technology platform and …

Read More »

Merck Serono Partners with Illumina to Develop a University NGS-Based Oncology Diagnostic

Illumina announced that it is partnering with Merck Serono to develop a universal oncology diagnostic that uses next-generation sequencing (NGS). The companies will collaborate to develop a universal NGS-based oncology diagnostic for clinical trials of targeted cancer therapies, with the goal of a more comprehensive tool for precision medicine. The …

Read More »

Quest Diagnostics Announces Availability of Exclusive Whole Exome Sequencing Service for Diagnosis of Pediatric Neurological Disorders

Quest Diagnostics announced that it is now offering a whole exome sequencing service aimed to enhance the diagnosis of rare neurological disorders in pediatric population. The leading provider of diagnostic information services today announced the availability of Neurome, a whole exome sequencing service. Leading genomics-based diagnostic laboratory, Personalis, Inc. developed …

Read More »